Economics of coronary stenting and GPIIb/IIIa blockade
- PMID: 11482914
- DOI: 10.1053/euhj.2001.2704
Economics of coronary stenting and GPIIb/IIIa blockade
Comment on
-
Cost-efficacy in interventional cardiology; results from the EPISTENT study. Evaluation of Platelet IIb/IIIa Inhibitor For Stenting Trial.Eur Heart J. 2001 Aug;22(16):1476-84. doi: 10.1053/euhj.2000.2543. Eur Heart J. 2001. PMID: 11482921
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
